Randomised, open-label, three-way crossover study investigating the bioavailability of methotrexate administered via a Medi-Jet Auto-injector or orally in adults with rheumatoid arthritis
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2013
Price : $35 *
At a glance
- Drugs Methotrexate (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Antares Pharma
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 16 Oct 2013 Results will be presented at the 2013 American College of Rheumatology (ACR) Annual Meeting, according to an Antares Pharma media release.
- 24 Jun 2013 New trial record